A recent outbreak of bacterial meningitis in the Democratic Republic of Congo (DRC) has resulted in at least nine deaths, raising concerns among health officials. The outbreak, which began in February, highlights the ongoing threat of infectious diseases and the importance of vaccination and rapid medical intervention.
According to the African Centres for Disease Control and Prevention (CDC), 24 suspected cases have been reported, with three confirmed. The fatality rate currently stands at 38%, which is considered incredibly high. Yap Boum, the assistant manager of incident management at the CDC, detailed the situation in a recent virtual press conference.
The outbreak originated in a school dormitory and has since spread to six villages within the Mangembo health zone in the Kongo Central province. The majority of those affected are students between the ages of 13 and 24.
The causative agent has been identified as Neisseria meningitidis serogroup W135. This particular strain is not covered by the current routine vaccination programs, which primarily protect against serogroup A. This lack of coverage underscores the need for adaptable vaccination strategies to address emerging strains of the disease.
Meningitis is an inflammatory disease of the membranes surrounding the brain and spinal cord. While preventable through vaccination and treatable with antibiotics when detected early, the illness can progress rapidly and become fatal, particularly in children and adolescents, if immediate medical care is not received.
A previous outbreak in 2022 caused 20 deaths and 75 infections from a serogroup C bacteria, which was also not covered by the vaccine available at that time.
Health authorities have deployed incident management teams to the affected province and are strengthening preparedness and response plans, case management, and risk communication efforts to control the spread of the disease.
Information from EFE
